The Urethral Stricture Treatment Devices market is witnessing a surge majorly due to the rising prevalence of cancers in the pelvic region such as colorectal and prostate cancers wherein the cancer treatment is linked with an increased probability of Urethral Stricture formation. Also, the growing prevalence of benign prostatic hyperplasia in which Urethral Stricture may form as a complication of surgical interventions might be a factor for the rising demand for Urethral Stricture Treatment Devices. Moreover, the entrance of key companies such as Boston Scientific Corporation, Laborie, Cook, Teleflex Incorporated, among others is responsible for the Global Urethral Stricture Treatment Devices market growth. It is anticipated that the Global Urethral Stricture Treatment Devices market will grow at a CAGR of 7.10% during the forecast period from 2021 to 2026 to reach USD 2.08 billion by 2026.
DelveInsight’s Urethral Stricture Treatment Devices Market Insights and Forecast report provides the current and forecast Urethral Stricture Treatment Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers, and barriers, market growth trends, and key competitors in the Urethral Stricture Treatment Devices Market.
Urethral Stricture Treatment Devices
A Urethral Stricture Treatment Devices is a medical device that helps in treating the narrowing of the urethra by opening it up and helping in the passage of urine. Urethral dilators, urology balloons, and urethral stents among other interventions.
Urethral Stricture Treatment Devices Market Insight
Geographically, the Global Urethral Stricture Treatment Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. Among all the regions, North America is estimated to account for the largest share in the Urethral Stricture Treatment Devices market. This domination is due to the increase in the prevalence of sexually transmitted diseases, the increasing prevalence of cancers in the region. Furthermore, the rising geriatric population, as well as growing cases of obesity in the US population, are also expected to result in the growing number of urethral strictures in the North American region. Additionally, extensive research and development activities pertaining to product development and a conducive regulatory environment further helps product manufacturers to generate more revenue from the region.
For instance, in December 2021, Urotronic received regulatory approval from the US Food and Drug Administration for their product- Optilume, a drug-coated urology balloon, which elutes a highly lipophilic drug, paclitaxel that limits hyperactive cell proliferation and the fibrotic scar tissue generation that results in stricture recurrence.
For more insights about the Urethral Stricture Treatment Devices market; download the snapshot of the key highlights entailed in the Urethral Stricture Treatment Devices Market Report
Recent Updates in the Urethral Stricture Treatment Devices Market
- In December 2021, Urotronic received regulatory approval from the US Food and Drug Administration for their product- Optilume, a drug-coated urology balloon, which elutes a highly lipophilic drug, paclitaxel that limits hyperactive cell proliferation and the fibrotic scar tissue generation that results in stricture recurrence.
- The Global Urethral Stricture Treatment Devices market is compact with less number of players. Allium Medical, a new player, has entered the Urethral Stricture Treatment Devices market with some uniqueness in the composition and better bio-compatibility in its products.
- The key Urethral Stricture Treatment Devices market players belonging to North American territories such as Canada and USA like are planning to expand their operations in order to treat problems like urinary infections, updated and advanced treatment at a comparatively lower cost for a satisfied customer base.
- Major Urethral Stricture Treatment Devices companies and the government is entering into a public-private partnership for generating awareness amongst the geriatric population, and hence, increasing the presence of the key Urethral Stricture Treatment Devices market players of different regions.
To pick on the latest highlights related to Urethral Stricture Treatment Devices Market, get the snapshot of the key highlights entailed in the Urethral Stricture Treatment Devices Report
Key Players in the Urethral Stricture Treatment Devices Market
Some of the leading Urethral Stricture Treatment Devices companies include Boston Scientific Corporation, Laborie, Cook, Teleflex Incorporated, B. Braun Melsungen AG, Allium Ltd., Pnn Medical A/S, Zhejiang ChuangXiang Medical Technology co., LTH, UROMED Kurt Drews KG, Med pro-Medical B.V., BD, Cardinal Health. Coloplast, ConvaTec Inc, BACTIGUARD AB, and others.
Click here to understand more about the Urethral Stricture Treatment Devices Market Forecast @ Urethral Stricture Treatment Devices Future Assessment
Urethral Stricture Treatment Devices Market Dynamics
The Urethral Stricture Treatment Devices market is gaining momentum due to the rising prevalence of cancers in the pelvic region such as colorectal and prostate cancers wherein the cancer treatment is linked with an increased probability of urethral stricture formation. In addition to that, growing prevalence of benign prostatic hyperplasia in which Urethral Stricture may form as a complication of surgical interventions, increasing geriatric population wherein aging plays a major role in the development of numerous diseases such as neurogenic bladder leading to the development of Urethral Strictures due to extensive use of urinary catheters. Also, advancements in product development such as drug-eluting urology balloons are anticipated to boost the growth of the Urethral Stricture Treatment Devices market during the forecast period.
However, device-related complications and the availability of alternative surgical approaches such as urethroplasty may be limiting factors for the growth of the Urethral Stricture Treatment Devices market. The Urethral Stricture Treatment Devices market registered a period of decline in revenue generation due to the COVID-19 pandemic. The lockdown implemented by various governments worldwide to contain the spread of the COVID-19 infection resulted in the postponement of outpatient consultations and various surgeries across all medical specialties specifically impacting elective procedures. Furthermore, the implementation of global lockdown also impacted the procurement and supply chain leading to obstruction for Urethral Stricture Treatment Devices market growth.
Interested in knowing about the advancements in the Urethral Stricture Treatment Devices market? Click to get a snapshot of Urethral Stricture Treatment Devices Market Developments
Scope of the Urethral Stricture Treatment Devices Market Report
- Coverage: Global
- Study Period: 2021-2026
- Market Segmentation By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, And Urinary Catheters
- Market Segmentation By Stricture Location: Anterior Urethral Stricture And Posterior Urethral Stricture
- Market Segmentation By End-User: Hospitals, Specialty Clinics, And Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Urethral Stricture Treatment Devices Companies: Boston Scientific Corporation (NYSE: BSX), Laborie, Cook, Teleflex Incorporated, B. Braun Melsungen AG, Allium Ltd., Pnn Medical A/S, Zhejiang ChuangXiang Medical Technology co., LTH, UROMED Kurt Drews KG, Med pro-Medical B.V., BD, Cardinal Health. Coloplast, ConvaTec Inc, BACTIGUARD AB, and others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Delveinsight Analysis: Global Urethral Stricture Treatment Devices market size was valued at USD 1.38 billion in 2020, growing at a CAGR of 7.10% during the forecast period from 2021 to 2026 to reach USD 2.08 billion by 2026.
Know more about which MedTech player is set to emerge as the trendsetter in Urethral Stricture Treatment Devices Industry @ Key Urethral Stricture Treatment Devices Companies Analysis
Table of Contents
| 1 | Urethral Stricture Treatment Devices Market Report Introduction |
| 2 | Urethral Stricture Treatment Devices Market Executive summary |
| 3 | Urethral Stricture Treatment Devices Market Regulatory and Patent Analysis |
| 4 | Urethral Stricture Treatment Devices Market Key Factors Analysis |
| 5 | Urethral Stricture Treatment Devices Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Urethral Stricture Treatment Devices Market |
| 7 | Urethral Stricture Treatment Devices Market Layout |
| 8 | Urethral Stricture Treatment Devices Market Global Company Share Analysis – Key 3-5 Companies |
| 9 | Urethral Stricture Treatment Devices Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Learn more about the report offerings @ Urethral Stricture Treatment Devices Market Outlook
Related Reports
DelveInsight’s Urinary Catheters Market Insights and Forecast report delivers an in-depth understanding of historical and forecasted Urinary Catheters market trends, market drivers, market barriers and key companies involved such as B. Braun Melsungen AG, Hangzhou Formed Medical Devices Co., Ltd., Boston Scientific Corporation, Cook, ConvaTec Inc., Becton, Dickinson, and Company., Teleflex Incorporated, and others.
Intrauterine Pressure Catheters Market
DelveInsight’s ‘Intrauterine Pressure Catheters Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Intrauterine Pressure Catheters and the historical and forecasted Intrauterine Pressure Catheters market trends, market drivers, market barriers and key companies involved such as Koninklijke Philips N.V, Utah Medical Products, Cardinal Health, CooperSurgical Inc, BD, Thomas Medical, Vyaire Medical, Terumo Europe NV, and others.
DelveInsight’s ‘Dialysis Catheters Market Insights, Competitive Landscape and Market Forecast–2026’ report deliver an in-depth understanding of Dialysis Catheters and the historical and forecasted Dialysis Catheters market trends, market drivers, market barriers, and key companies involved such as Amecath Medical Technologies, Haidylena, Teleflex Incorporated, Nipro Corporation, Medtronic, Baxter, Wellex Medical, BD, and others.
Chest Drainage Catheters Market
DelveInsight’s ‘Chest Drainage Catheters Market Insights, Competitive Landscape and Market Forecast – 2026’ report delivers an in-depth understanding of Chest Drainage Catheters and the historical and forecasted Chest Drainage Catheters market trends, market drivers, market barriers and key companies involved such as Terumo Corporation, Teleflex Incorporated, Rocket Medical plc, Cook Medical Incorporated, Medline Industries, Maquet Holding B.V. and Co. KG, Utah Medical Products, Inc, Vygon SA, Smiths Medical, and others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Get in touch with our team to get more detailed insights on how the MedTech Market is expected to evolve in the coming years and to formulate innovative business solutions, at Healthcare Due Diligence Services
Contact Us
Shruti Thakur
+1(919)321-6187